Loading…
Loading…
Get a deeper insight into the potential performance of Welltower (WELL) for the quarter ended June 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
VNQ dominates on returns with 14.9% gains over one year, while HAUZ offers lower costs and exposure to international property markets.
WELL heads into Q2 earnings with revenues and normalized FFO growth expected, backed by senior housing demand and muted supply.
America's demographic clock keeps ticking, and the money is following the wrinkles.
Most REITs rallied, but rare bargains still dipped. Major transformations are creating overlooked upside. 5%+ yields offer income while waiting for recovery.
The aging of America has made healthcare stocks an evergreen investment theme. It's also a reason for investors to consider looking at real estate investment trusts (REITs) focused on this area.
Welltower grew revenue and normalized funds from operations by double-digit percentages. Sabra has a dividend that yields above 6%.
Welltower gets a buy for my initial rating, as it presents both a compelling dividend idea and a capital growth idea. Top-line revenue growth is proven over 5 years already, as the portfolio keeps expanding through acquisition, with a recent acquisition in Canada. The stock is favorably covered both by Moody's and Barclays.
Full call transcripts — prepared remarks + analyst Q&A — with speaker-by-speaker formatting and one-click switching across every quarter on file.
Click below to see what's inside, then upgrade to read every transcript for WELL and 80,000+ other tickers.
Transcripts source: company-published earnings calls. Speaker attribution and formatting are processed in-app.